Professor Paul Amminger

Prof Amminger is a Psychiatrist, Head of Neuroprotective Biotherapies Research at Orygen, and Professor of Neurobiology and Neuroprotection in Emerging Mental Disorders at the Centre of Youth Mental Health, University of Melbourne. He pioneered the use of omega-3 fatty acids for preventing psychosis in young people at high risk, providing an avenue for early intervention. He is engaged in clinical trials research testing agents with favourable risk-benefit ratio for treatment and preventive use in young people with mental health problems.